Literature DB >> 21778832

Sebaceous carcinoma: an immunohistochemical reappraisal.

Shin-ichi Ansai1, Hiromi Takeichi, Seiji Arase, Seiji Kawana, Tetsunori Kimura.   

Abstract

The rates of distant metastases and tumor death in sebaceous carcinoma (SC) have been reported to be higher than those of other cutaneous carcinomas, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), regardless of whether they occur in ocular or extraocular regions. Therefore, strict differentiation of SC from SCC and BCC is required. In this article, we report immunohistochemical findings of SC and compare these data to those of SCC, BCC, and sebaceoma. An immunohistochemical study was performed using 7 antibodies [anti-carcinoembryonic antigen (CEA), anti-epithelial membrane antigen (EMA), anti-CA15-3, anti-CA19-9, anti-androgen receptor (AR), anti-epithelial antigen (Ber-EP4), and anti-adipophilin (ADP)] on 35 cases of SC (16 cases in ocular and 19 cases in extraocular regions) and 10 cases of each SCC (5 cases in ocular and 5 cases in extraocular regions), BCC (5 cases in ocular and 5 cases in extraocular regions), and sebaceoma (no cases arose on the eyelids). In summary, the typical immunophenotypes of SC were EMA+, CA15-3+, AR+, Ber-EP4-, and ADP+; those of sebaceoma were CEA-, EMA+, Ber-EP4-, and ADP+; those of SCC were CEA-, EMA+, CA19-9-, AR-, Ber-EP4-, and ADP-; and those of BCC were CEA-, EMA-, CA15-3-, Ber-EP4+, and ADP-. Other antibody tests for each neoplasm were positive in about half of the cases. The detection of AR and ADP was useful for differentiating SC from SCC, whereas the determination of EMA, CA15-3, Ber-EP4, and ADP was valuable in differentiating SC from BCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778832     DOI: 10.1097/DAD.0b013e31820a2027

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  14 in total

1.  My journey into the world of salivary gland sebaceous neoplasms.

Authors:  Douglas R Gnepp
Journal:  Head Neck Pathol       Date:  2012-03-20

Review 2.  Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

Authors:  Pia R Mendoza; Hans E Grossniklaus
Journal:  Int Ophthalmol Clin       Date:  2015

3.  Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.

Authors:  Eva Janine Schmitz; Martina C Herwig-Carl; Frank G Holz; Karin U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-24       Impact factor: 3.117

Review 4.  [Differential diagnostics of sebaceous tumors].

Authors:  A Böer-Auer
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

5.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

6.  Multifocal metastasizing extra-ocular facial sebaceous carcinoma as diagnostic challenge: case report and systematic review.

Authors:  Irina Bolm; Gregor Babaryka; Maximilian Moergel; Bilal Al-Nawas; Peer W Kämmerer
Journal:  J Maxillofac Oral Surg       Date:  2013-06-20

7.  Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma.

Authors:  Bahar Dasgeb; Tarana M Mohammadi; Darius R Mehregan
Journal:  Biomark Cancer       Date:  2013-06-25

8.  Aggressive extraocular sebaceous carcinoma recurring after mohs micrographic surgery.

Authors:  Konstantin V Grigoryan; Laurel Leithauser; Hugh M Gloster
Journal:  Case Rep Oncol Med       Date:  2015-01-22

9.  Sebaceous carcinoma on the abdomen in an African-American male patient.

Authors:  Talitha C Moon; Nicole M Cassler; Jeffrey N Lackey
Journal:  Indian Dermatol Online J       Date:  2015-12

10.  Simulators of squamous cell carcinoma of the skin: diagnostic challenges on small biopsies and clinicopathological correlation.

Authors:  Kong-Bing Tan; Sze-Hwa Tan; Derrick Chen-Wee Aw; Huma Jaffar; Thiam-Chye Lim; Shu-Jin Lee; Yoke-Sun Lee
Journal:  J Skin Cancer       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.